Healthcare & Life Sciences

Omnix Medical

series-c-plus
series-c-plus
Stage
2
Investors

About

Omnix Medical is a biopharmaceutical company developing novel antibiotic agents targeting drug-resistant bacteria, focusing on creating stable and selective antimicrobial peptides for treating resistant infections.

Explore Omnix Medical's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.